ACHIEVE LIFE SCIENCES, INC. (ACHV) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-02

ACHIEVE LIFE SCIENCES, INC. (ACHV) has filed 4 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-02. 3 Form 8-K material event filings were reported by ACHV in the last 90 days. InsiderAlpha tracks every ACHV SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About ACHIEVE LIFE SCIENCES, INC. (ACHV)

SIC classification	In Vitro & In Vivo Diagnostic Substances (SIC 2835)
SEC CIK	0000949858

90-Day SEC Filing Activity

Form 4 filings (90d)	4
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-06-02

Recent ACHV Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-09-18	Oki Mark K	Chief Financial Officer	M — Option exercise	168.0K	$0.00	—	SEC
2025-09-18	Oki Mark K	Chief Financial Officer	S — Open-market sale	50.1K	$2.92	$146K	SEC
2025-09-18	Stewart Richard Alistair	Chief Executive Officer	M — Option exercise	297.5K	$0.00	—	SEC
2025-09-18	Stewart Richard Alistair	Chief Executive Officer	S — Open-market sale	129.5K	$2.92	$378K	SEC
2025-09-04	Xinos Jaime	Chief Commercial Officer	M — Option exercise	69.0K	$0.00	—	SEC
2025-09-04	Xinos Jaime	Chief Commercial Officer	S — Open-market sale	20.9K	$2.77	$58K	SEC
2025-09-04	Wan Jerry	Principal Accounting Officer	M — Option exercise	34.1K	$0.00	—	SEC
2025-09-04	JACOBS CINDY	President CMO	M — Option exercise	110.0K	$0.00	—	SEC
2025-09-04	Wan Jerry	Principal Accounting Officer	S — Open-market sale	14.1K	$2.77	$39K	SEC
2025-09-04	JACOBS CINDY	President CMO	S — Open-market sale	27.6K	$2.77	$77K	SEC
2025-09-04	KING THOMAS BRAXTON	Insider	M — Option exercise	455.0K	$0.00	—	SEC
2025-09-04	KING THOMAS BRAXTON	Insider	S — Open-market sale	139.9K	$2.77	$387K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for ACHIEVE LIFE SCIENCES, INC. (ACHV). Updated in real time as new filings are submitted to the SEC.

Most-Active ACHV Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Goldberg Andrew D.	3	—
Martin Christopher Nathan	1	—
Waldman Reid Alexander	1	—
Farrow Jeffrey S	1	—

Recent ACHV Form 8-K Material Events

2026-07-06 — Item 5.03, 5.07, 9.01 [SEC]
2026-06-02 — Item 5.02 [SEC]
2026-05-12 — Item 2.02, 5.02, 9.01 [SEC]
2026-04-16 — Item 1.01, 3.02, 5.02, 7.01, 9.01 · Financing · mixed [SEC]
Achieve Life Sciences completed a private placement on April 15, 2026, issuing approximately 49.4 million shares of common stock and pre-funded warrants, plus accompanying common warrants to purchase up to 49.5 million shares, at a collective purchase price of $3.63-$3.64 per uni
2026-03-24 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Achieve Life Sciences issued a press release on March 24, 2026 announcing its financial results for the fourth quarter and full year ended December 31, 2025. The filing provides standard financial reporting without explicit beat/miss or guidance language.

Recent Insider Filings

2026-06-02 — Waldman Reid Alexander (Insider)
2026-06-02 — Farrow Jeffrey S (Insider)
2026-05-13 — Martin Christopher Nathan (Insider)
2026-04-21 — Goldberg Andrew D. (CEO and President)
2026-01-30 — Rubinstein Mark Lawrence (Chief Medical Officer)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ACHV insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ACHV Insider Trading — FAQ

What is the latest insider trade for ACHV?: ACHIEVE LIFE SCIENCES, INC. (ACHV) had 4 insider filings in the last 90 days, with the most recent on 2026-06-02. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ACHV stock?: 0 insider purchases of ACHV were filed in the last 90 days.
How many insiders are selling ACHV stock?: 0 insider sales of ACHV were filed in the last 90 days.
Where can I see ACHV SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ACHV SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live ACHV dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.